Results 181 to 190 of about 136,614 (358)

Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono‐Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 2, Page 254-263, January 2026.
Hepatitis B immunoglobulins withdrawal in hepatitis B virus mono‐infected liver transplant recipients: An Italian multicentre prospective study. ABSTRACT Background & Aims Despite recommendations from scientific societies that hepatitis B immunoglobulin (HBIG) can be safely discontinued, centres across Europe continue to use the combination nucleoside ...
Raffaella Viganò, Alessandro Loglio, Clara Dibenedetto, Paola Carrai, Silvia Martini, Ilaria Lenci, Bianca Magro, Sara Conti, Paolo Angelo Cortesi, Chiara Mazzarelli, Chiara Becchetti, Giovanni Perricone, Monica Cucco, Marco Carbone, Donatella Cocchis, Elisa Farina, Luisa Pasulo, Mauro Viganò, Michele Sagasta, Elisabetta Degasperi, Davide Ghinolfi, Pietro Lampertico, Stefano Fagiuoli, Luca Saverio Belli, on behalf of the INSIGHT‐B study group   +24 more
wiley   +1 more source

Mindray CL-900i Assay: An Effective assay for HBsAg Screening with Superior Specificity [PDF]

Gheyath K. Nasrallah, Salma Younes, Nadin Younes, Parveen B. Nizamuddin, Maryam A Alabdulmalek, Khadija N. Mohammad, Dayana El Chaar, Manal Elshaikh, Mazen Najib Abouassali, Ibrahim Wissam Karimeh, Mohammed Abdelfatah Ibrahim, Mutaz Mohamed Ali, Ibrahim Al Shaar, Zhu Louyin, Palanee Ammaranond, Laith J. Abu‐Raddad, Ahmed Ismail   +16 more
openalex   +1 more source

People living with HIV on modern antiretrovirals do not display a pro‐atherogenic lipid profile and have similar body composition compared to healthy controls

HIV Medicine, Volume 27, Issue 1, Page 86-95, January 2026.
Abstract Objectives Alterations in lipids and apolipoproteins contribute to cardiovascular disease (CVD) and are common in people with HIV. The aim of our study was to compare lipid profiles and body composition between people with and without HIV and to explore whether any associations with HIV could be explained by socio‐demographic, clinical ...
S. Savinelli, A. Heeney, W. Tinago, A. A. Garcia Leon, P. McGettrick, A. G. Cotter, I. Walsh, M. Fitzgibbon, C. A. Sabin, P. W. G. Mallon, E. R. Feeney, on behalf of the HIV UPBEAT study group   +11 more
wiley   +1 more source

Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria

, 2014
BT Utoo
openalex   +2 more sources

Hepatitis B Virus Infection in Vaccinated Children and Adolescents with HBsAg-positive Parents: Is Routine Vaccination Sufficient? [PDF]

, 2022
Alireza Bakhshipour, Manijeh Khalili, Raheleh Rafaiee   +2 more
openalex   +1 more source

Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025

HIV Medicine, Volume 27, Issue 1, Page 18-32, January 2026.
Abstract Background The European AIDS Clinical Society (EACS) guidelines were revised for the 21st time in 2025, with updates covering all aspects of HIV care. Key Points of the Guidelines Update The structure of the guidelines has been reorganized into two parts: Part I focuses on the management and prevention of HIV and related infections, and Part ...
Juan Ambrosioni, Laura I. Levi, Jasmini Alagaratnam, Abiu Sempere, Andrea Mastrangelo, Paolo Paioni, Cristina Mussini, Catia Marzolini, Susanne Dam Nielsen, Charles Béguelin, Steven Welch, Anna Koval, Luis Mendao, Alasdair Bamford, Alexandra Calmy, Giovanni Guaraldi, Cristiana Oprea, Esteban Martínez, Jürgen K. Rockstroh, The EACS Governing Board   +19 more
wiley   +1 more source

A Male-ABCD Algorithm for Hepatocellular Carcinoma Risk Prediction in HBsAg Carriers [PDF]

, 2021
Yuting Wang, Minjie Wang, He Li, Kun Chen, Hongmei Zeng, Xinyu Bi, Zheng Zhu, Yuchen Jiao, Yong Wang, Jian Zhu, Huijun Zhao, Xiang Liu, Chunyun Dai, Chunsun Fan, Can Zhao, Deyin Guo, Hong Zhao, Sizhen Wang, Jianguo Zhou, Dongmei Wang, Zhiyuan Wu, Xinming Zhao, Wei Cui, Xuehong Zhang, Jianqiang Cai, Wanqing Chen, Chunfeng Qu   +26 more
openalex   +1 more source

Disrupting Viral Persistence: CRISPR/Cas9‐Based Strategies for Hepatitis B and C Treatment, and Challenges

Journal of Cellular and Molecular Medicine, Volume 30, Issue 1, January 2026.
ABSTRACT Hepatitis B and C viruses (HBV and HCV) remain among the leading causes of liver disease worldwide. Current antiviral drugs, such as nucleotide analogues (NAs), can reduce the replication of new HBV and HCV infections but cannot completely eliminate chronic infections.
Meng‐Fan Li, Akmal Zubair, Safa Wdidi, Shan He   +3 more
wiley   +1 more source

Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States

Journal of Viral Hepatitis, Volume 33, Issue 1, January 2026.
ABSTRACT Hepatitis D virus (HDV) screening rates in the United States are low. We evaluated the impact of double reflex‐based HDV testing on HDV‐related morbidity and mortality in the United States. A Screen and Treat model simulated the HDV screening cascade (decision tree) and assessed the natural history of HDV (Markov model) over a 5‐year time ...
Robert J. Wong, Robert G. Gish, Ira M. Jacobson, Joseph K. Lim, Marvin Rock, Csilla Kinyik‐Merena, Hanxiao Ma, Nathaniel Smith, Chong Kim   +8 more
wiley   +1 more source

Rapid HBsAg Decline Can Predict HBsAg Seroclearance Only in Patients With HBsAg <200 IU/mL

Clinical and Translational Gastroenterology
Yi-Cheng Chen, Yun-Fan Liaw
openaire   +2 more sources